Chinese Pharmaceuticals & Biotech Undervalued Dividend Payers

Yunnan Baiyao GroupLtd

Market Cap: CN¥100.3b

Engages in the pharmaceutical business in China.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥50.0b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Beijing Tongrentang

Market Cap: CN¥40.9b

Engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally.

Dong-E-E-JiaoLtd

Market Cap: CN¥33.4b

Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.

Livzon Pharmaceutical Group

Market Cap: CN¥28.0b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

Tasly Pharmaceutical Group

Market Cap: CN¥21.0b

Researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally.

China Resources Jiangzhong PharmaceuticalLtd

Market Cap: CN¥15.8b

Engages in the manufacture of pharmaceutical products in China.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥14.7b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

KPC PharmaceuticalsInc

Market Cap: CN¥9.2b

A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.

Wuhan Keqian BiologyLtd

Market Cap: CN¥7.4b

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.